Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.6 EUR | +0.59% | +1.58% | +8.93% |
Apr. 19 | Capgemini: new platform implemented for Bayer | CF |
Apr. 18 | CAPGEMINI : Oddo BHF adjusts its price target | CF |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.93% | 37.46B | B | ||
-11.12% | 199B | A- | ||
+0.99% | 168B | B+ | ||
+11.37% | 167B | B- | ||
+5.37% | 101B | A- | ||
+6.27% | 78.31B | A- | ||
+16.57% | 72.48B | C- | ||
-7.27% | 71.7B | A | ||
-22.91% | 50.48B | C | ||
+0.90% | 48.34B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CAP Stock
- Ratings Capgemini SE